Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/19/2005EP1585525A1 Use of thiazolobenzoheterocycles for treating multiple sclerosis
10/19/2005EP1585524A2 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
10/19/2005EP1585523A2 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1585520A1 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/19/2005EP1585519A1 High concentration formulations of opioids and opioid derivatives
10/19/2005EP1585518A2 Peptide deformylase inhibitors
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1585516A2 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
10/19/2005EP1585515A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
10/19/2005EP1585514A1 Method for the medicinal prophylaxis of cholinesterase inhibitor intoxication, and active substances and medicaments suitable therefor
10/19/2005EP1585513A1 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
10/19/2005EP1585512A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1585510A1 Alpha-aminoamide derivatives useful as antimigraine agents
10/19/2005EP1585509A1 Sphingolipids for improvement of the composition of the intestinal flora
10/19/2005EP1585508A2 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels
10/19/2005EP1585507A2 The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis
10/19/2005EP1585502A1 Fast-disintegrating solid dosage forms being not friable and comprising pullulan
10/19/2005EP1585501A1 Sustained-release preparations and method for producing the same
10/19/2005EP1585497A1 Mastitis treatment
10/19/2005EP1585485A2 Compositions for the reduction of hair growth
10/19/2005EP1585483A1 Topical stabilized prostaglandin e compound dosage forms
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/19/2005EP1585470A2 Transdermal delivery of fentanyl
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1461045A4 Glucosamine organic acid adducts
10/19/2005EP1439830B1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
10/19/2005EP1432683B1 Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1414446B1 Pramipexol as an anticonvulsive agent
10/19/2005EP1406902B1 Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1401837B1 Purine derivatives as a2b adenosine receptor antagonists
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1346045B1 Human protooncogene and protein encoded therein
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1307245B1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
10/19/2005EP1307186A4 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
10/19/2005EP1273299B1 Minoxidil-containing preparations
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1254131B1 Extraction of flavonoids
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1240142B1 New modulators of dopamine neurotransmission
10/19/2005EP1237539B1 Oral solution containing galanthamine and a sweetening agent
10/19/2005EP1216059B1 Composition for ivf
10/19/2005EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/19/2005EP1202993B1 Phenanthroline-7-one derivatives and their therapeutic uses
10/19/2005EP1202728B1 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins.
10/19/2005EP1200095B1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
10/19/2005EP1175155A4 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/19/2005EP1173217B1 Enhanced delivery of nucleic acid-based drugs
10/19/2005EP1165061B1 Use of compound preparation made of vitamin d metabolites or vitamin d analogues and partial estrogen agonists for treating osteoporosis
10/19/2005EP1165055B1 Pharmaceutical composition containing estradiol or ethinylestradiol and an extrusion additive
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005EP1144373B1 Serine protease inhibitors
10/19/2005EP1137635B1 N-substituted 2-cyanopyrrolidines
10/19/2005EP1131056B1 Particles based on polyamino-acid(s) and methods for preparing same
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005EP1091743B1 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
10/19/2005EP1086071B1 Hyperforin derivatives, the use thereof and formulations containing them
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005EP1073656B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
10/19/2005EP1070714A9 Amidine compounds
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005EP1047471B1 Systems for local delivery of an agent
10/19/2005EP1036057B1 Radio-opaque polymer biomaterials
10/19/2005EP1017415B1 Product for promoting dural or meningeal tissue growth comprising collagen
10/19/2005EP1016406B1 Ophthalmic compositions for soft contact lens comprising terpenoid
10/19/2005EP1011672B1 Use of (e)-metanicotine derivatives for eliciting analgesic effects
10/19/2005EP0968013B1 Coated implantable medical device
10/19/2005EP0966446B1 Bicyclic inhibitors of protein farnesyl transferase
10/19/2005EP0918539B1 Vaccine for b-cell malignancies
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0831891B1 Oxidant scavengers
10/19/2005EP0801565B1 Use for topical application of tocotrienol to the skin and hair
10/19/2005EP0793499B1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound
10/19/2005EP0774949B1 Denture adhesive
10/19/2005CN1685227A Bioequivalence test for iron-containing formulations
10/19/2005CN1685063A Methods and compositions relating to gene silencing
10/19/2005CN1685008A Synergistic UV absorber combination
10/19/2005CN1684971A Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying co
10/19/2005CN1684967A N-substituted hydromorphones and the use thereof
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684965A Novel 1, 4-diazabicycloalkane derivatives, their preparation and use
10/19/2005CN1684964A Use of and some novel imidazopyridines
10/19/2005CN1684963A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via novel 1H-imidazo [4, 5-C] quinolin-4-cyano and 1H-imidazo [4, 5-C] quinolin-4-carboxamide intermediates
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684956A Total synthesis of myriaporones
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
1 ... 4500 4501 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 ... 7860